Description
WEBINAR PROGRAM
Herbal Alternatives to Drugs
Internal medicine is an integral part of both western and traditional Chinese medicine. Both medicines have advantages and disadvantages in regards to diagnosis, treatment, and prevention.
Integrate the knowledge and understanding of Traditional Chinese Medicine (TCM) and Western pharmacological perspectives into your treatment of internal disorders! Join Dr. John Chen, a doctor in both Western pharmacology and Chinese Medicine and author of Chinese Medical Herbology and Pharmacology and Chinese Herbal Formulas & Applications, as he discusses herbal alternatives to drugs for the following internal conditions:
- Hyperlipidemia
- Gastrointestinal disorders
- Clotting disorders
- Asthma
- Emotional disorders
- Hypothyroidism
- Hypertension
- Edema
- Diabetes
- Infection
- Allergies
- Reproductive disorders
- Inflammatory disorders
- Osteoporosis
In order to learn how to achieve optimal treatment results with minimal side effects or adverse reactions, it is imperative that healthcare practitioners understand both western and traditional Chinese medicine systems so they can help their patients make clear and informed decisions.
About John Chen (Pharm.D., Ph.D., O.M.D., L.Ac.)
Dr. John Chen is a recognized authority in both western pharmacology and Chinese Herbal Medicine, having combined formal training in both fields with extensive research ‘on the ground’ in China. He teaches at the USC School of Pharmacy, Emperor’s College, Yo San University of TCM, OCOM, Five Branches, AOMA and ACTCM, and has taught numerous professional seminars across the U.S. and internationally. Dr. Chen’s published works include Chinese Medical Herbology and Pharmacology (2003, AOM Press), Chinese Herbal Formulas and Applications (2008, AOM Press), and Chinese Herbal Formulas for Veterinarians (2012, AOM Press) for which works he is the lead author.
What You Get After You Complete The Course
- Notes to keep
- 5.5 CPD Points
- CPD Certificate
- 5 year access
- Unlimited revisions during access period
Reviews
There are no reviews yet.